SCHEMBL400758

SCHEMBL400758

COCOc1c(OC)cc(C(=O)OC)cc1C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.43
TSHR P16473 2/20 0.43
MAPT P10636 5/20 0.42
LMNA P02545 3/20 0.42
GAA P10253 1/20 0.42
KDM4E B2RXH2 2/20 0.40
EGFR P00533 1/20 0.40
MRGPRX4 Q96LA9 1/20 0.40
USP2 O75604 1/20 0.39
CYP3A4 P08684 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MEN1 O00255 2/20 0.37
HTT P42858 2/20 0.37
KMT2A Q03164 2/20 0.37
THRB P10828 1/20 0.37
CNR2 P34972 1/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
CYP2D6 P10635 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL402248 0.84 NOTUM (0.56) NOTUMTSHRMAPTLMNAGAA
SCHEMBL25337123 0.82 NOTUM (0.44) NOTUMTSHRMAPTLMNAGAA
SCHEMBL402764 0.80 TSHR (0.50) TSHRMAPTLMNAGAAKDM4E
SCHEMBL398872 0.79 BPTF (0.56) TSHRMAPTKDM4EEGFRUSP2
SCHEMBL10205503 0.79 SMN1; SMN2 (0.53) TSHRMAPTLMNAGAAKDM4E
SCHEMBL5204737 0.79 TSHR (0.51) NOTUMTSHRMAPTKDM4EUSP2
SCHEMBL23202788 0.78 EGFR (0.48) TSHRMAPTLMNAGAAKDM4E
SCHEMBL8779698 0.77 EGFR (0.48) NOTUMTSHRMAPTLMNAGAA
SCHEMBL402234 0.77 NOTUM (0.50) NOTUMMAPTLMNAGAAKDM4E
SCHEMBL3545784 0.76 KDM4E (0.49) NOTUMTSHRMAPTLMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
EP-1803452-A1 ESTER DERIVATIVE AND PHARMACEUTICAL USE THEREOF Japan Tobacco, Inc. (JP) 2007-07-04 EP disclosed
US-20060089392-A1 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089392-A1 Ester derivatives and medicinal use thereof MTTP, CETP, LIPA NOTUM 34/4885TSHR 1411/4885MAPT 3451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.